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Sir, 
In their recent paper 1, Hynes et al. described the use of morphological features of the tumour 
microenvironment on H&E stained tissue sections for routine assessment of prognosis in stage II/III 
colon cancer patients. One of these features is the tumour stromal percentage (TSP), which was 
described by our group in 20072. Although we appreciate the fact that this method is widely used 
and validated, unfortunately Hynes and colleagues misinterpreted the method described by Mesker 
et al. This had led to the definition of two separate methodologies, i.e. focal and global assessment 
of the tumour stromal percentage. However, we would like to report that their definition of global 
scoring as the method used by Mesker et al. which they describe as ‘an estimation of the tumour 
stromal percentage at scanning magnification’ is misinterpreted. We acknowledge that the method 
section of the Mesker paper 2 first states that the carcinoma percentage (NB. stromal percentage or 
TSR in later papers) is estimated on the whole tumour area. However, a detailed protocol is given 
further on in the paragraph: “H&E sections of the tumor with the most invasive part of the primary 
tumor were chosen. Using a 2.5x or a 5x objective the invasive area with the desmoplastic stroma 
was selected. Subsequently, using a 10x objective only the fields were scored where the stroma was 
infiltrated with small tumor nests within all sides of the image field. The tumor percentage was 
estimated (per tenfold: 10, 20, 30% etc.) per image field.” This means that both focal and global 
assessment as defined by Hynes et al. are in fact the same methods. In addition, both Huijbers  
et al. 3 and Park et al. 4 adapted their methods from the methodology of the Mesker paper. 
Moreover, the paper of Huijbers et al. is in fact also from the same research group. 
As Park et al. already stated in their comment to this paper of Hynes et al. 5, it is of interest that the 
assessment of TSP was not associated with survival in this study population. Hynes and colleagues 
described a considerable variation between study participants in the selection of ‘the most invasive 
field’, and expect this to be a greater problem with more tumour slides to evaluate in daily practice. 
As stated in the method section of the Mesker paper, the lowest scored tumour percentage (i.e. the 
highest scored stromal percentage) is decisive for final analyses. Therefore, the number of slides to 
be evaluated should not influence the final score. However, recognizing the most invasive field of a 
slide might have influence on the selection of the field of scoring. Not in all slides the structure of the 
colon is still recognisable due to the infiltration of the tumour into the tissue or the way the tissue is 
embedded in paraffin, and the most invasive field cannot be determined.  
It is now in our opinion, based on experience, that it is not necessary to select the most invasive field 
within each slide, as the slides used for evaluation are already from the most invasive part of the 
tumour. This is confirmed by later published results on scoring the stromal percentage in colon 
cancer, and in other epithelial cancer types as well6-8. 
It would be of interest to analyse if the results published by Hynes and colleagues would change if 
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